LENIOBIO
LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.
LENIOBIO
Industry:
Biotechnology
Founded:
2016-01-01
Address:
Düsseldorf, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.leniobio.com
Total Employee:
11+
Status:
Active
Contact:
+49 211 890940300
Email Addresses:
[email protected]
Total Funding:
14.25 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Apache Nginx Gravatar Profiles
Similar Organizations
Current Advisors List
Current Employees Featured
Investors List
Eurostars
Eurostars investment in Grant - LenioBio
Bridford Group
Bridford Group investment in Series A - LenioBio
Official Site Inspections
http://www.leniobio.com Semrush global rank: 6.9 M Semrush visits lastest month: 706
- Host name: linux180.unoeuro.com
- IP address: 93.191.156.30
- Location: Langeskov Denmark
- Latitude: 55.3565
- Longitude: 10.5845
- Timezone: Europe/Copenhagen
- Postal: 5550
More informations about "LenioBio"
LenioBio | Delivering Your Challenging Proteins
Jan 7, 2022 · Discover LenioBio's innovative protein expression technology, ALiCE®, for rapid and scalable protein production. Ideal for research, drug development, and industrial applications.See details»
About Us | LenioBio: Innovators in Protein Expression
Jan 7, 2022 · LenioBio is a life sciences biotech company, pioneering a disruptive protein expression platform. Using our ALiCE® technology, we enable our customers – researchers and biopharma manufacturers -to streamline and …See details»
LenioBio - Crunchbase Company Profile & Funding
LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production. LenioBio may be growing as it has recently received funding, which is a strong indicator of financial growth and …See details»
History and Origin | LenioBio
Jan 7, 2022 · Aware of an experimental cell-free protein production technology that had the potential to achieve just this, Remberto established LenioBio with a singular objective: to …See details»
LenioBio Company Profile 2024: Valuation, Funding
Developer of cell-free protein expression products designed to harness the power of nature to accelerate synthetic biology. The company's products include a range of tools for the rapid, affordable, scalable, and reliable expression of any …See details»
LenioBio - Funding, Financials, Valuation & Investors - Crunchbase
LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.See details»
LenioBio Appoints CTO and CCO to Spearhead Growth and …
DUSSELDORF, Germany, Feb. 22, 2024 /PRNewswire/ -- LenioBio, a life-science company offering an advanced protein expression platform for drug discovery and development, today …See details»
LenioBio - Products, Competitors, Financials, Employees, …
LenioBio specializes in protein expression solutions through biotechnology. The company's technology ALiCE is a scalable eukaryotic platform for cell-free protein expression. It was …See details»
Meet our Team | LenioBio
Jan 7, 2022 · Meet the exceptional individuals who form the backbone of LenioBio. Our team comprises diverse professionals, ranging from brilliant scientists and talented researchers to dedicated engineers and visionary leaders.See details»
LenioBio - EU-Startups
LenioBio is a biotech company that develops and markets a novel, unique and proprietary protein production platform, ALiCE, which enables protein-based therapeutics to become more …See details»
LenioBio Appoints CTO and CCO to Spearhead Growth and …
Feb 22, 2024 · LenioBio, a life-science company offering an advanced protein expression platform for drug discovery and development, today announced the appointments of Kathrin Knauf as …See details»
LenioBio reaches industrial-scale with its high-yield eukaryotic ...
DÃœSSELDORF, Germany, June 8, 2022 /PRNewswire/ -- LenioBio GmbH today announced it had achieved a key milestone for the company with the successful linear scaling of its cell-free …See details»
LenioBio closes its Series-A Extension round and strengthens its …
DÃœSSELDORF, Germany, March 7, 2022 /PRNewswire/ -- LenioBio GmbH, a German life sciences biotech offering a disruptive protein manufacturing technology, ALiCE®, closed its …See details»
LenioBio collaborates with ReciBioPharm to scale up ALiCE
October 2 nd, 2024 — LenioBio, the leader in rapid cell-free protein expression technologies, is pleased to announce a collaboration with ReciBioPharm, a global contract development and …See details»
Expert Protein Production and Purification Service | LenioBio
Jan 7, 2022 · We provide an end-to-end protein service for research-grade protein expression. From cloning to expression and purification, we enable our customers to unlock new potential …See details»
LenioBio: Pioneering Cell-Free Protein Expression to ... - Biocompare
LenioBio aims to simplify manufacturing and accelerate the delivery of drugs to patients. The company emerged from the challenges faced during the 2015 Ebola outbreak, where existing …See details»
LenioBio announces appointment of new Chief Business Officer to ...
Jan 7, 2022 · Dusseldorf, August 4th 2022 – LenioBio GmbH, the German life science biotech offering a disruptive protein manufacturing technology, today announced the appointment of …See details»
LenioBio Reviews: What Is It Like to Work At LenioBio?
Feb 14, 2024 · Glassdoor has 8 LenioBio reviews submitted anonymously by LenioBio employees. Read employee reviews and ratings on Glassdoor to decide if LenioBio is right for …See details»
LenioBio Collaborates with ReciBioPharm to Scale Up ALiCE® …
DUSSELDORF, Germany, Oct. 2, 2024 /PRNewswire/ -- LenioBio, the leader in rapid cell-free protein expression technologies, is pleased to announce a collaboration with ReciBioPharm, a …See details»
LenioBio Press Releases: Latest News & Updates
Jan 7, 2022 · LenioBio, the leader in rapid cell-free protein expression technologies, is pleased to announce a collaboration with ReciBioPharm, a global contract development and …See details»